Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Top Lilly exec plays secret sales agent
Here's a little secret about Eli Lilly's U.S. president Deidre Connelly (photo): She likes to go undercover. At a recent industry conference, Connelly confided that she sometimes goes on the road as a mild-mannered pharma rep. That way, she gets the on-the-ground skinny on what her sales force is up against. (Recently, she tried to strike up a conversation with a doc who'd ignored her; he demanded to know who she was. When he saw her title on her business card, he asked, "President? President of what?")
The main thrust of Connelly's speech, though, was about what she sees as a necessary evolution in pharma sales techniques. Reps can't be all about one-way communication, but need to promote give and take so they can actually help physicians solve problems. That sort of approach requires knowledge, and lots of it, so Connelly's in favor of building up specialty sales teams from within the company.
- read this post from Pharmalot
- read the report from Medical Marketing & Media
Related Articles:
In speech, Lilly CEO calls for drug monitoring. Report
No freebies? No entry for pharma reps. Report
Groups plan new fight to limit pharma-doctor ties. Report
Thinking through pharma bans. Editorial
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


